feed,title,long_url,short_url
Benzinga,Novartis' Tislelizumab Extends Overall Survival In Late-Stage Esophageal Cancer Study,https://benzinga.com/general/biotech/22/06/27912495/novartiss-tislelizumab-extended-overall-survival-in-late-stage-esophageal-cancer-study,https://bit.ly/3a73oY3
